Build your career on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.
Join Kite to help advance cancer therapies and shape where our business and medical science goes next.
We are looking for an organized, proactive and detail-oriented Technical Project Manager to join our Hoofddorp, the Netherlands manufacturing site. This position will be responsible for leading and executing from definition to handover multiple biopharmaceutical Technical Capital Projects and own financial project controls within our Capital Portfolio. Our new Project Manager will deliver ‘best in class’ projects that meets strict safety, quality, capital and schedule requirements.
The ideal candidate will have good experience of leading all aspects of end-to-end Project management within medium to high complexity Capital Projects, combined with a strong strategic mindset.
Responsibilities
Requirements
Gilead's Core Values
About Gilead and Kite
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions.
Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors.
For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, changing the paradigm of cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago.
View what's on offer:
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.